Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MEDTRONIC PLC

(MDT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Medtronic : Argus Adjusts Medtronic's Price Target to $165 From $150, Reiterates Buy Rating

08/27/2021 | 08:40am EST


ę MT Newswires 2021
All news about MEDTRONIC PLC
11/24JPMorgan Adjusts Medtronic's Price Target to $130 from $148, Keeps Overweight Rating
MT
11/24Bernstein Adjusts Medtronic's Price Target to $143 from $148, Keeps Outperform Rating
MT
11/24Raymond James Adjusts Medtronic's Price Target to $127 from $142, Keeps Outperform Rati..
MT
11/24Stifel Adjusts Medtronic's Price Target to $140 from $145, Keeps Buy Rating
MT
11/24Truist Securities Adjusts Medtronic's Price Target to $142 from $148, Keeps Buy Rating
MT
11/24Wells Fargo Adjusts Medtronic's Price Target to $137 From $144, Reiterates Overweight R..
MT
11/24Oppenheimer Adjusts Price Target on Medtronic to $145 From $150, Maintains Outperform R..
MT
11/24Morgan Stanley Adjusts Price Target on Medtronic to $145 From $154, Maintains Overweigh..
MT
11/24Citigroup Adjusts Medtronic's Price Target to $146 From $153, Reiterates Buy Rating
MT
11/23Needham Adjusts Medtronic's Price Target to $145 From $152, Maintains Buy Rating
MT
More news
Analyst Recommendations on MEDTRONIC PLC
More recommendations
Financials (USD)
Sales 2022 32 396 M - -
Net income 2022 5 378 M - -
Net Debt 2022 22 296 M - -
P/E ratio 2022 28,4x
Yield 2022 2,24%
Capitalization 149 B 149 B -
EV / Sales 2022 5,30x
EV / Sales 2023 4,90x
Nbr of Employees 90 000
Free-Float 99,8%
Chart MEDTRONIC PLC
Duration : Period :
Medtronic plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDTRONIC PLC
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 27
Last Close Price 111,05 $
Average target price 141,32 $
Spread / Average Target 27,3%
EPS Revisions
Managers and Directors
Geoffrey Straub Martha Chairman & Chief Executive Officer
Karen L. Parkhill Chief Financial Officer & Executive Vice President
Laura Mauri Chief Clinical & Regulatory Officer, Senior VP
Richard E. Kuntz Chief Medical & Scientific Officer, Senior VP
Gregory L. Smith Executive VP-Global Operations & Supply Chain
Sector and Competitors
1st jan.Capi. (M$)
MEDTRONIC PLC-2.30%153 906
ABBOTT LABORATORIES14.23%221 160
BECTON, DICKINSON AND COMPANY-2.30%69 432
HOYA CORPORATION27.96%59 234
DEXCOM, INC.61.90%58 016
ALIGN TECHNOLOGY, INC.22.24%51 507